Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Collection of Whole Blood Specimens of Subjects Diagnosed With Preeclampsia With Severe Features and/or Fetal Growth Restriction in Support of a Molecular Assay Development

NCT02808494 is registered in ClinicalTrials.gov with Illumina, Inc. as lead sponsor.

NCT NCT02808494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02808494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Collection of Whole Blood Specimens of Subjects Diagnosed With Preeclampsia With Severe Features and/or Fetal Growth Restriction in Support of a Molecular Assay Development
Lead sponsor
Illumina, Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2016
Completion date
November 20, 2017
Enrollment
242 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

preeclampsia